Listen for Questions About Meds to Prevent RSV in Young Children
October 2023
Nirsevimab-alip (Beyfortus) will be a new med to prevent respiratory syncytial virus (RSV) in young children.
You’ll hear nirsevimab called a vaccine...since it’s an intramuscular (IM) injection that provides protection against RSV. But it’s a monoclonal antibody that’s given in a clinic or hospital.
Nirsevimab joins palivizumab (Synagis)...another injectable monoclonal antibody to prevent serious illness from RSV.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote